Search
Loading search results...
Search Results for "PCSK9 Inhibitors: Access Barriers Affect Real People"
PCSK9 Inhibitors: Access Barriers Affect Real People
Overcoming Access Barriers for PCSK9 Inhibitors
A Real World Approach to LDL cholesterol using PCSK9 inhibitors, October 5 2018
PCSK9 Inhibition: Lowering Lipids and Reducing Cardiovascular Events
The Cholesterol Wars: Identifying Patients Who Would Most Benefit from PCSK9 Inhibitors (Part 1)
Ann Marie Navar, EASD 2019: Safety profile of PCSK9 inhibitors
Clinical Experience With PCSK9 Inhibitors
PCSK9 Inhibitors within the Targeted Treatment Approach to Hypercholesterolemia 4/26/16
PCSK9 Inhibitors: Cost Concerns and Access
A Discussion with 2 Authors of the Family Heart Foundation Research Paper on PCSK9 Inhibitors - FULL
Overcoming Access Barriers and Practice Challenges to PCSK9 Inhibitor Implementation
Diagnosing and Treating Hyperlipidemia: Recent Evidence and the Role of PCSK9-targeted Therapies